>Thanks to advances in early diagnosis and cancer treatment, more and more cancer patients are surviving
Zero tolerance for data fraud Shandong sets key points for carbon emission verification
Time of Update: 2022-05-20
The Shandong Provincial Department of Ecology and Environment officially launched the bidding work for the carbon emission verification and management review project of key emission units in 2021 on the evening of the 25th .
Announcement of latest persistence and booster data for Clover's new coronary pneumonia adjuvanted protein vaccine
Time of Update: 2022-05-18
A new dataset from an extended follow-up analysis confirms earlier findings and shows high and durable protection in individuals approximately 6 months after basal immunization with SCB-2019 (CpG 1018/aluminum adjuvant) .
Sanofi Announces Summary Data from Clinical Trial of New Transplant Drug Rezurock
Time of Update: 2022-05-17
Pooled analyses from the ROCKstar (KD025-213) and KD025-028 studies show a very strong, but not generalized, correlation between organ clinical response measures and clinically meaningful changes in PRO in patients treated with Rezurock .
The procurement data of immune analysis equipment in the first quarter of 2022 was announced, down nearly 60% year-on-year
Time of Update: 2022-05-17
Data source: JOINCHAIN® Ranking of Zhongcheng Digital Distributors According to the winning bid results, the distributor with the highest total sales in the first quarter of 2022 is Beijing Huazheng Boyan Technology Co.
BASF releases first quarter data
Time of Update: 2022-05-16
Net income was well below the year-ago period and also well below analysts' average forecast for the first quarter of 2022 (1.
Amgen Announces New Data from Two OLE Studies of PCSK9 Inhibitor Repatha in ASCVD
Time of Update: 2022-05-16
CompilenewbornRecently, Amgen announced the top-line results of two open-label extension (OLE) studies of the PCSK9 inhibitor lipid-lowering drug Repatha (Repatha, generic name: evolocumab) Phase 3 FOURIER cardiovascular outcomes trial .
Largest study of whole-genome sequencing data reveals 'treasure house' of clues to cancer etiology
Time of Update: 2022-05-16
> >DNA analysis of thousands of patients' tumors by the NHS has uncovered a "treasure" of cancer causes, with genetic mutations providing
Science: Large-scale cancer WGS data reveal dozens of new mutational signatures
Time of Update: 2022-05-15
individual . With thousands of mutations in every cancer, we have unprecedented capabilities in the NHS. Looking for commonalities and differences among patients, in doing so, we discovered 58 new mutational
A&R: Recreational Physical Activity and Risk of Knee Osteoarthritis: An International Meta-Analysis of Individual Participant Data
Time of Update: 2022-05-13
RESULTS: Based on a total of 5065 participants, the pooled RR estimated the association of MET days per week with painful radiological OA ( RR 1.
Nat Med uses artificial intelligence to safely detect cancer from patient data
Time of Update: 2022-05-13
Swarm learning trains artificial intelligence algorithms to detect patterns in local hospital or university data, such as genetic changes in images of human tissue .
in dynamic process analysis and data-driven modeling of phototherapy
Time of Update: 2022-05-11
> Calculating the production of singlet oxygen during PDT
Environmental monitoring data - the "lifeline" of pharmaceutical production that cannot be ignored!
Time of Update: 2022-05-05
Only through complete, high-quality, true and accurate data monitoring can we ensure that the pollutants in the pharmaceutical process better meet the relevant national standards .
The world's first freeze-dried mRNA vaccine preclinical data release How is the progress of mRNA vaccine at home and abroad?
Time of Update: 2022-05-03
According to the 221-year financial report released by Pfizer earlier, the total revenue of the new crown vaccine Comirnaty reached 36.
The latest data of Arvinas androgen receptor PROTAC therapy show sustained anti-tumor activity
Time of Update: 2022-05-03
February 21, 2022/eMedClub PR News/--On February 17, 2022, Arvinas, a clinical-stage biotechnology company, announced the completion of bavdegalutamide, a novel PROTAC® protein degrader targeting the androgen receptor (AR).
After ASCO GU 2022: Interpretation and reflection on mCSPC real-world data
Time of Update: 2022-05-02
A022 From February 17th to 19th, the ASCO-GU conference was held offline in San Francisco, USA.
On the first day, it not only released
What safety data support is needed for the clinical advancement of innovative drugs?
Time of Update: 2022-05-02
TextMedicine Crazy
The three attributes of medicines are safe, effective, and quality
